Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
09/04/1997 | WO1997031893A1 Process for scavenging thiols |
09/04/1997 | WO1997031654A1 Nitric oxide donors capable of reducing toxicity from drugs |
09/04/1997 | WO1997031636A1 Novel indole and benzothiazole derivatives |
09/04/1997 | CA2247901A1 Proton pump inhibitor |
09/04/1997 | CA2247899A1 Process for scavenging thiols |
09/04/1997 | CA2247802A1 Soluble tachykinin antagonists, the preparation and use thereof |
09/04/1997 | CA2247208A1 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
09/04/1997 | CA2246813A1 Novel indole and benzothiazole derivatives |
09/03/1997 | EP0792643A1 Use of an aldose reductase inhibitor for reducing non-cardiac tissue damage |
09/03/1997 | EP0792365A1 Immunogens for stimulating mucosal immunity |
09/03/1997 | EP0792279A1 Antibiotic cryptdin peptides and methods of their use |
09/03/1997 | EP0792265A1 Endothelin antagonists |
09/03/1997 | EP0792168A1 Novel tumor suppressor gene, hic-1 |
09/03/1997 | EP0792162A1 Use of antibodies to block the effects of gram-positive bacteria and mycobacteria |
09/03/1997 | EP0792150A1 2-(2,3,5,6-tetrafluoro-4-pyridyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof |
09/03/1997 | EP0792110A1 Silicone compositions |
09/03/1997 | EP0656905B1 Calcium channel blocking polypeptide from agelenopsis aperta |
09/03/1997 | EP0647616B1 Zinc tranexamate compound |
09/03/1997 | EP0647226B1 9-AMINOPYRIDAZINO 4',5' : 3,4]pyrrolo 2,1-a]ISOQUINOLINES AND THEIR USE IN THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS |
09/03/1997 | EP0391905B1 Use of disaccharide polysulfate-aluminium compound in the manufacture of a medicament for treating HEMORRHOIDs and for wound healing |
09/03/1997 | CN1158253A 明龙肝宝乙肝药及其制配方法 Ming-Long Bao liver and hepatitis B drug distribution system method |
09/02/1997 | US5663380 Cysteine protease inhibitors containing heterocyclic leaving groups |
09/02/1997 | US5663375 Cell proliferation |
09/02/1997 | US5663352 4-phenyl-4-phenylpropyl(enyl)-piperidines as tachykinin antagonists |
09/02/1997 | US5663349 Multistage process of reduction and amination of aminopyridines |
09/02/1997 | US5663334 Process for preparing pyrimidyl imidazoles |
09/02/1997 | US5663173 Central nervous system disorders, cognition activators, pychoses, antidepressants and eating disorders |
09/02/1997 | US5663156 Mixture of higher primary aliphatic alcohols, its obtention from sugar cane wax and its pharmaceutical uses |
09/02/1997 | US5663151 Sulfated α-glycolipid derivatives as cell adhesion inhibitors |
08/28/1997 | WO1997030998A1 Azabicyclic esters of carbamic acids useful in therapy |
08/28/1997 | WO1997030990A1 Novel substituted n-methyl-n-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases |
08/28/1997 | WO1997030989A1 Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl-amino)piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases |
08/28/1997 | WO1997030720A1 Method of producing an enterosorbent |
08/28/1997 | WO1997030711A1 External preparation for curing lesioned tissues |
08/28/1997 | WO1997030677A2 Pentafluorobenzenesulfonamides and analogs |
08/28/1997 | WO1997030601A1 Liquid oral compositions comprising a calcium compound and an acidulant |
08/28/1997 | WO1997019702A3 Powdery iodine complexes |
08/28/1997 | CA2247206A1 External preparation for curing lesioned tissues |
08/28/1997 | CA2246051A1 Azabicyclic esters of carbamic acids useful in therapy |
08/27/1997 | EP0791592A2 Azetidines |
08/27/1997 | EP0791577A1 Ortho-substituted benzylguanidines, process for their preparation and their use as medicament or diagnostic agent as well as medicament containing them |
08/27/1997 | EP0791355A1 Method of reducing tissue damage associated with ischemia |
08/27/1997 | EP0790998A1 Azo derivatives of 5-aminosalicylic acid for treatment of inflammatory bowel disease |
08/27/1997 | EP0790831A1 Method for reducing the severity of gastro-intestinal damage |
08/27/1997 | EP0681476B1 Unit dose form of bismuth subsalicylate |
08/27/1997 | CN1158128A Novel polymorphs of lesopitron dichlorohydrate and its hydrated forms, preparation method and compositions |
08/27/1997 | CN1158121A Indolizine SPLA2 inhibitors |
08/27/1997 | CN1158086A Methods of inhibiting endometrial mitoses |
08/27/1997 | CN1157822A Pharmaceutical compounds |
08/27/1997 | CN1157735A Refreshing tea |
08/27/1997 | CN1157717A Application of oxidized matrine in preparing medine for treatment of hepatitis B. |
08/26/1997 | US5661162 4-aminomethyl/thiomethyl/sulfonylmethyl-4-phenylpiperdines as tachykinin receptor antagonists |
08/26/1997 | US5661007 Culturing; recovering; purification; administering to induce bone and/or cartilage formation |
08/26/1997 | US5660859 Gelation of low-molecular weight polymer in water using calcium acetate at room temperature; drug capsules; dental products; cosmetics; cariers |
08/26/1997 | US5660842 Administering at least one monoglyceride of fatty acid as bactericides |
08/26/1997 | CA2069931C Muscarinic receptor antagonists |
08/26/1997 | CA1339365C Oligopeptides and intermediates and processes for their manufacture |
08/22/1997 | CA2198176A1 Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
08/21/1997 | WO1997030056A1 Spiro-ketal derivatives and their use as therapeutic agents |
08/21/1997 | WO1997030055A1 Spiro-ketal derivatives and their use as therapeutic agents |
08/21/1997 | WO1997030048A1 1,4-dihydropyridine compounds as bradykinin antagonists |
08/21/1997 | WO1997030046A1 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists |
08/21/1997 | WO1997030045A1 Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
08/21/1997 | WO1997030042A1 Polyester cyclic compounds, their complexes and bonded bodies |
08/21/1997 | WO1997029763A1 Urogenital and intestinal disorder compositions comprising a substance derived from plant species of the ericaceae family and a lactic acid bacteria growth factor |
08/21/1997 | WO1997029762A1 Urogenital and intestinal compositions |
08/21/1997 | WO1997029739A2 Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhibitors |
08/21/1997 | WO1997023613A3 Cell activation process and reagents therefor |
08/21/1997 | WO1997023507A3 New form of amphiregulin, methods for producing and using the same and compositions comprising the same |
08/21/1997 | CA2634973A1 Novel benzo-1,3-dioxolyl-and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
08/21/1997 | CA2246371A1 Urogenital and intestinal disorder compositions comprising a substance derived from plant species of the ericaceae family and a lactic acid bacteria growth factor |
08/21/1997 | CA2245810A1 Urogenital and intestinal compositions |
08/21/1997 | CA2245684A1 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists |
08/20/1997 | EP0790254A1 Pseudopeptides derived from neurokinines, process of preparation and pharmaceutical compositions comprising them |
08/20/1997 | EP0790248A1 3-Aza-piperidone- (tetrahydropyrimidin-2-one) and 3-oxa-piperidone (1,3 oxazin-2-one) derivatives, their preparation and their use as tachykinin/neurokinin antagonists |
08/20/1997 | EP0790239A1 Novel 4-phenyl-2-(piperazinyl/perhydrodiazepinyl/aminoalkyl)carbonylmethyl)-1,4-dihydropyridine-3,5-dicarboxylic acid derivatives as bradykinin receptor antagonists |
08/20/1997 | EP0789571A1 Cyclic amidine analogs as inhibitors of nitric oxide synthase |
08/20/1997 | EP0789569A2 Use of benzothiophenes and benzofurans for the treatment of inflammatory bowel disease and inflammation assay method |
08/20/1997 | EP0789553A1 Antiodor, antimicrobial and preservative compositions and methods of using same |
08/20/1997 | EP0629197B1 1-alkoxy-(2-alkoxy- or cycloalkoxy)-4-(cyclo thioalkyl- or cyclothioalkenyl)benzenes as inhibitors of cyclic amp phosphodiesterase and tumour necrosis factor |
08/20/1997 | EP0579833B1 Ethanolamine derivatives with anti-pollakiuria activity |
08/20/1997 | CN1157615A Heterocyclic tachykinin receptor antagonists |
08/20/1997 | CN1157614A Process for synthesis of substituted sulphoxides |
08/20/1997 | CN1157136A Pharmaceutical agents for treatment of acute and chronic inflammatory diseases |
08/20/1997 | CN1035670C Method for preparing benzoheterocyclic compounds or its salt |
08/19/1997 | US5658940 Inhibitors of tumor necrosis factor |
08/19/1997 | US5658925 Aminobenzoic acid derivatives |
08/19/1997 | US5658913 Thiopyrazine derivatives; enzyme inhibitor of phase 1 reaction to prevent the formation of activated toxic intermediate metabolites and induce phase ll conjugation reactions to promote excretion of toxics |
08/19/1997 | US5658908 Opioid diarylmethylpiperazines and piperdines |
08/19/1997 | US5658897 Cyclopentane(ene) heptanoic or cyclopentane(ene) heptenoic acid, 2-hydrocarbyl phosphinyloxyalkyl or phosphonamidoalkyl as therapeutic agents |
08/19/1997 | US5658888 Enterokinesis stimulating action |
08/19/1997 | US5658885 Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes |
08/19/1997 | US5658882 Methods of inducting formation of tendon and/or ligament tissue comprising administering BMP-12, BMP-13, and/or MP-52 |
08/19/1997 | US5658776 Generation of high titers of recombinant AAV vectors |
08/19/1997 | CA2020633C Mutant of pseudomonas, a strain yzh, and a process for producing 851 yzh nutrient solution by application of the strain |
08/19/1997 | CA2008078C Use of dimethylpolysiloxane for the treatment of disorders of the gastrointestinal tract |
08/19/1997 | CA1339338C Composition and a process for inducing binding between parts of living mineralized tissue |
08/19/1997 | CA1339301C2 Antibacterial antiplaque, anticalculus oral composition |
08/17/1997 | CA2197611A1 Pseudopeptides derives from neurokinins and their preparation process |
08/14/1997 | WO1997029131A1 HUMAN ANTIBODIES THAT BIND HUMAN TNF$g(a) |